Huw Jones
Chief Executive Officer presso THERACRYF PLC
Patrimonio netto: 691 $ in data 31/03/2024
Profilo
Huw Jones is currently the Chief Executive Officer & Director at Evgen Pharma Plc, the Chairman at Chronos Therapeutics Ltd., and a Non-Executive Director at Ixaka Ltd.
He previously served as the Non-Executive Chairman at Sinclair Pharma UK Ltd.
from 2002 to 2006, as a Non-Executive Director at Ardana Plc from 2006 to 2010, and as the President at CV Therapeutics, Inc. Dr. Jones holds a doctorate degree from the University of Birmingham.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
THERACRYF PLC
0.02% | 14/12/2022 | 62 500 ( 0.02% ) | 691 $ | 31/03/2024 |
Posizioni attive di Huw Jones
| Società | Posizione | Inizio |
|---|---|---|
| THERACRYF PLC | Chief Executive Officer | 01/10/2020 |
Chronos Therapeutics Ltd.
 Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Chairman | - |
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Director/Board Member | 12/02/2020 |
Precedenti posizioni note di Huw Jones
| Società | Posizione | Fine |
|---|---|---|
Sinclair Pharma UK Ltd.
 Sinclair Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Sinclair Pharma UK Ltd. provides pharmaceutical services. The company work closely with dispensing doctors to provide products and services that support rural dispensing and help to generate an income for practices. The company was founded in 1984 and is located in Surrey, the United Kingdom. | Chairman | 01/01/2006 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | President | - |
Ardana Plc
 Ardana Plc Pharmaceuticals: MajorHealth Technology Ardana Plc developed pharmaceuticals products. It offered Invicorp, an intracavernosal injectable combination of phentolamine mesilate and vasoactive intestinal polypeptide for the treatment of male erectile dysfunction. The company was founded in 2000 and was headquartered in Bristol, the United Kingdom. | Chief Executive Officer | - |
Formazione di Huw Jones
| University of Birmingham | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| THERACRYF PLC | Health Services |
| Aziende private | 5 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Ardana Plc
Ardana Plc Pharmaceuticals: MajorHealth Technology Ardana Plc developed pharmaceuticals products. It offered Invicorp, an intracavernosal injectable combination of phentolamine mesilate and vasoactive intestinal polypeptide for the treatment of male erectile dysfunction. The company was founded in 2000 and was headquartered in Bristol, the United Kingdom. | Health Technology |
Sinclair Pharma UK Ltd.
Sinclair Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Sinclair Pharma UK Ltd. provides pharmaceutical services. The company work closely with dispensing doctors to provide products and services that support rural dispensing and help to generate an income for practices. The company was founded in 1984 and is located in Surrey, the United Kingdom. | Commercial Services |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Huw Jones
